| Entry |
|
|---|
| Name |
Vonicog alfa (USAN);
Vonicog alfa (genetical recombination) (JAN);
Von willebrand factor;
Wilfactin (TN);
Vonvendi (TN)
|
|---|
| Formula |
C9712H15373N2737O3032S210
|
|---|
| Exact mass |
225574.4238
|
|---|
| Mol weight |
225723.1487
|
|---|
| Class |
Cardiovascular agent
DG02016 Hemostatics
DG02013 Blood coagulation factor
DG02014 Blood coagulation accelerant
DG02013 Blood coagulation factor
|
|---|
| Remark |
| Therapeutic category: | 6349 |
|
|---|
| Efficacy |
Anticoagulant, Hemostatic, Replenisher (von Willebrand factor) |
|---|
| Comment |
recombinant von Willebrand factor (vWF) [HSA: 7450] [KO: K03900]
Prophylactic treatment of bleeding episodes and Von Willebrand disease
|
|---|
| Interaction |
|
|---|
| Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
B BLOOD AND BLOOD FORMING ORGANS
B02 ANTIHEMORRHAGICS
B02B VITAMIN K AND OTHER HEMOSTATICS
B02BD Blood coagulation factors
B02BD10 von Willebrand factor
D08681 Vonicog alfa (USAN) <JP>
Therapeutic category of drugs in Japan [BR:br08301]
6 Agents against pathologic organisms and parasites
63 Biological preparations
634 Human blood preparations
6349 Others
D08681 Vonicog alfa (USAN); Vonicog alfa (genetical recombination) (JAN)
New drug approvals in Europe [br08329.html]
European public assessment reports (EPAR) authorised medicine
D08681
New drug approvals in Japan [br08318.html]
Drugs with new active ingredients
D08681
New drug approvals in the USA, Europe and Japan [br08328.html]
Approval dates by FDA, EMA and PMDA
D08681
 |
|---|
| Other DBs |
|
|---|
| LinkDB |
 |
|---|
